Dr. Hildebrandt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One Hospital Drive
Columbia, MO 65212Phone+1 573-882-8445Fax+1 573-884-6292- Is this information wrong?
Education & Training
- Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1997
Certifications & Licensure
- MO State Medical License 2022 - 2025
- KY State Medical License 2014 - 2025
- LA State Medical License 2009 - 2017
- UT State Medical License 2012 - 2015
Clinical Trials
- Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- A dyadic analysis of financial toxicity and health-related quality of life among bone marrow transplant patients and their caregivers.Jean S Edward, Mary Kay Rayens, Laurie E McLouth, Lori P Eisele, Joan Scales, Lovoria B Williams, Gerhard Hildebrandt> ;Psycho-Oncology. 2024 Feb 1
- Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.Abid, M. B., Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V Michelis, Taiga Nishihori, Mrinal Pat...> ;Blood Advances. 2023 Nov 28
- Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study.Leo I Gordon, Fei Fei Liu, Julia Braverman, Daanish Hoda, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C Hildebrandt, Lily Peng, Shien Guo, Ling Shi, Alison Sehgal> ;Haematologica. 2024 Mar 1
- Join now to see all
Journal Articles
- Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect
Abstracts/Posters
- Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based StudyGerhard C. Hildebrandt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Includi...Gerhard C. Hildebrandt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Lisocabtagene Maraleucel (liso-cel) for Treatment of Second-Line Transplant Noneligible (TNE) Relapsed/Refractory (R/R) Aggressive Non-Hodgkin Lymphoma (NHL): Initial ...Gerhard C. Hildebrandt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Ellis Fischel Cancer Center Becomes AACI’s Newest MemberDecember 27th, 2022
- Siteman to Collaborate with University of Missouri on Cancer Research, with Aim to Improve CareSeptember 20th, 2022
- Researchers Discover Potential Treatments for Common Complication Following Bone Marrow TransplantFebruary 15th, 2024
Hospital Affiliations
- University HospitalColumbia, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: